[go: up one dir, main page]

FR2765221B1 - Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique - Google Patents

Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique

Info

Publication number
FR2765221B1
FR2765221B1 FR9707900A FR9707900A FR2765221B1 FR 2765221 B1 FR2765221 B1 FR 2765221B1 FR 9707900 A FR9707900 A FR 9707900A FR 9707900 A FR9707900 A FR 9707900A FR 2765221 B1 FR2765221 B1 FR 2765221B1
Authority
FR
France
Prior art keywords
anilide
imidazol
piperidin
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9707900A
Other languages
English (en)
Other versions
FR2765221A1 (fr
Inventor
Gerard Cremer
Marc Daumas
Marie Angele Adler
Genevieve Dellac
Veronique Rouannet
Christian Hoornaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9707900A priority Critical patent/FR2765221B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to EP98932237A priority patent/EP0991639A1/fr
Priority to AU82206/98A priority patent/AU8220698A/en
Priority to PCT/FR1998/001288 priority patent/WO1999000379A1/fr
Priority to JP50531399A priority patent/JP2002506458A/ja
Priority to ARP980103032A priority patent/AR013127A1/es
Priority to ZA985518A priority patent/ZA985518B/xx
Publication of FR2765221A1 publication Critical patent/FR2765221A1/fr
Application granted granted Critical
Publication of FR2765221B1 publication Critical patent/FR2765221B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9707900A 1997-06-25 1997-06-25 Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique Expired - Lifetime FR2765221B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9707900A FR2765221B1 (fr) 1997-06-25 1997-06-25 Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
AU82206/98A AU8220698A (en) 1997-06-25 1998-06-19 4-{(1h-imidazol-4-yl)piperidin-1-yl}anilide derivatives, their preparation and application in therapy
PCT/FR1998/001288 WO1999000379A1 (fr) 1997-06-25 1998-06-19 Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
JP50531399A JP2002506458A (ja) 1997-06-25 1998-06-19 ４−［（１ｈ−イミダゾール−４−イル）ピペリジン−１−イル］アニリド誘導体、それらの製造及び治療におけるそれらの応用
EP98932237A EP0991639A1 (fr) 1997-06-25 1998-06-19 DERIVES DE 4- (1$i(H)-IMIDAZOL-4-YL)PIPERIDIN-1-YL]ANILIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
ARP980103032A AR013127A1 (es) 1997-06-25 1998-06-24 Derivados de 4-[(1h-imidazol-4-il)piperidin-1-il]anilida, su preparacion y su aplicacion en terapeutica
ZA985518A ZA985518B (en) 1997-06-25 1998-06-24 4-[(1H-imidazol-4-YL) piperidin-1-YL] anilide derivatives their preparation and their application in therapeutics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9707900A FR2765221B1 (fr) 1997-06-25 1997-06-25 Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2765221A1 FR2765221A1 (fr) 1998-12-31
FR2765221B1 true FR2765221B1 (fr) 1999-07-30

Family

ID=9508386

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9707900A Expired - Lifetime FR2765221B1 (fr) 1997-06-25 1997-06-25 Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique

Country Status (7)

Country Link
EP (1) EP0991639A1 (fr)
JP (1) JP2002506458A (fr)
AR (1) AR013127A1 (fr)
AU (1) AU8220698A (fr)
FR (1) FR2765221B1 (fr)
WO (1) WO1999000379A1 (fr)
ZA (1) ZA985518B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
US7501889B2 (en) 2004-04-26 2009-03-10 Rgb Systems, Inc. Method and apparatus for implementing soft switching in a class D amplifier
JP6162694B2 (ja) 2011-07-18 2017-07-12 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ ベンズアミド類
WO2022173904A1 (fr) * 2021-02-12 2022-08-18 The Trustees Of Columbia University In The City Of New York Nouveaux composés comprenant une nouvelle classe de ligands de transthyrétine pour le traitement de comorbidités communes associées à l'âge

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2579596B1 (fr) * 1985-03-26 1987-11-20 Inst Nat Sante Rech Med (imidazolyl-4) piperidines, leur preparation et leur application en therapeutique
FR2671083B1 (fr) * 1990-12-31 1994-12-23 Inst Nat Sante Rech Med Nouvelles 4-(4-imidazolyl) piperidines substituees en 1, leur preparation ainsi que leurs applications therapeutiques.
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
FR2696177B1 (fr) * 1992-09-28 1995-05-12 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DE4325822A1 (de) * 1993-07-31 1995-02-02 Hoechst Ag Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
EP0991639A1 (fr) 2000-04-12
WO1999000379A1 (fr) 1999-01-07
AR013127A1 (es) 2000-12-13
ZA985518B (en) 1999-01-28
FR2765221A1 (fr) 1998-12-31
AU8220698A (en) 1999-01-19
JP2002506458A (ja) 2002-02-26

Similar Documents

Publication Publication Date Title
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FR2761071B1 (fr) Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2765221B1 (fr) Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
FR2772377B1 (fr) Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2765580B1 (fr) Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2688504B1 (fr) Derives de 2-(piperidin-1-yl)ethanol, leur preparation et leur application en therapeutique.
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2731707B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2772760B1 (fr) Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4- propanamide, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2727413B1 (fr) Derives de 5-(1h-imidazol-4-yl)-1-oxo-2-(phenylsulfonamino)- pentylpiperidine, leur preparation et leur application en therapeutique
FR2738568B1 (fr) Derives de 4-(cycloalkyl)piperidines et 4-(cycloalkylalkyl) piperidines, leur preparation et leur application en therapeutique